artara | Protara Therapeutics

Keyword	CPC	PCC	Volume	Score	Length of keyword
artara	1.38	0.6	4888	43	6

Keyword	CPC	PCC	Volume	Score
artarama	0.62	0.7	4782	2
artarama jerry's	0.07	0.1	6760	91
artarama art supplies	1.92	0.7	2691	44
atarax	0.1	0.5	1600	66
artara	0.58	0.7	2993	44
artaraz	0.68	0.4	7053	19
artaraya	1.64	0.2	5683	7
artaraya technologies	1.08	0.3	4251	25
artarama miami	1.66	0.5	7689	98
artarak artan grafik	1.81	0.3	5591	85
artarama 2024 self portrait contest	0.12	0.7	6286	8
artarakt	0.88	0.6	9092	70
artara therapeutics	0.88	0.6	7456	81
artarama austin	1.69	0.4	9633	24
artarama houston	1.86	0.7	4488	18
artarama norwalk ct	1.01	0.4	5245	54
artarama eagle river wi	1.29	0.8	7258	40
artarama ct	1.29	0.7	6223	10
artarama nyc	0.92	0.3	3513	1
altarama.com	0.03	0.9	2323	90
artarama frames	1.18	0.2	2225	65
artarama austin tx	1.81	0.6	249	76

Search Results related to artara on Search Engine

Protara Therapeutics
protaratx.com

https://protaratx.com/

WebProtara Therapeutics. tenacious in our search for transformative therapies. LEARN ABOUT US. TARA-002 is the Company’s lead investigational cell therapy based on the broad immunopotentiator OK-432, which is approved in Japan and Taiwan for multiple oncologic indications and lymphatic malformations (LMs).

DA: 27 PA: 5 MOZ Rank: 47

ArTara Therapeutics Announces Corporate Name Change to …
protaratx.com

https://ir.protaratx.com/news-releases/news-release-details/artara-therapeutics-announces-corporate-name-change-protara

WebMay 11, 2020. Download PDF. NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc ., effective immediately.

DA: 37 PA: 30 MOZ Rank: 43

ArTara Therapeutics Completes Merger Transaction with Proteon
protaratx.com

https://ir.protaratx.com/news-releases/news-release-details/artara-therapeutics-completes-merger-transaction-proteon

WebNEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA) (“ArTara” or the “Company”), a clinical-stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced the completion of the merger with Proteon Therapeutics, Inc. (“Proteon”) (Nasdaq: PRTO) and ...

DA: 11 PA: 53 MOZ Rank: 82

Proteon Therapeutics and ArTara Therapeutics Agree to Combine
protaratx.com

https://ir.protaratx.com/news-releases/news-release-details/proteon-therapeutics-and-artara-therapeutics-agree-combine

WebSep 23, 2019 · ArTara is a clinical stage therapeutics company focused on acquiring and modernizing high-potential, de-risked product candidates for rare and specialty diseases. ArTara’s current development programs focus on the treatment of rare diseases in structural and connective tissues as well as rare hepatology and metabolic disorders.

DA: 62 PA: 41 MOZ Rank: 67

ArTara Therapeutics Announces Additions to - Business Wire
businesswire.com

https://www.businesswire.com/news/home/20190204005578/en/ArTara-Therapeutics-Announces-Additions-Leadership-Team-Board

WebFeb 4, 2019 · ArTara is a rare diseases therapeutics company focused on optimizing therapeutics for patients suffering from rare diseases where there is a significant unmet need. ArTara’s initial focus is...

DA: 61 PA: 27 MOZ Rank: 46

Proteon Therapeutics to merge with ArTara Therapeutics
pharmaceutical-technology.com

https://www.pharmaceutical-technology.com/news/proteon-artara-therapeutics-merger/

WebThe combined company will advance ArTara’s pipeline, which includes late-stage, de-risked assets targeting rare and speciality diseases. A consortium of healthcare investors has entered into a stock purchase agreement to invest $42.5m in the merged company, which is set to operate as ArTara Therapeutics.

DA: 34 PA: 95 MOZ Rank: 59

ArTara Therapeutics Announces Initiation of New Immunology …
businesswire.com

https://www.businesswire.com/news/home/20190619005713/en/ArTara-Therapeutics-Announces-Initiation-New-Immunology-Pipeline

WebJun 19, 2019 · NEW YORK-- ( BUSINESS WIRE )--ArTara Therapeutics, a clinical-stage biopharmaceutical company developing treatments for rare diseases with significant unmet therapeutic needs, has initiated...

DA: 69 PA: 54 MOZ Rank: 69

ArTara Therapeutics, Inc. (Form: 10-K, Received: 03/20/2020 …
edgar-online.com

https://content.edgar-online.com/ExternalLink/EDGAR/0001171843-20-001860.html?hash=9fd08a155c7d43b59b668024f3628c77165e3e932cb0edebe41ba5af09dfa6a7&dest=EXH_1025_HTM

WebArTara has a very limited operating history and has never generated any revenues. ArTara is an early-stage biopharmaceutical company with a very limited operating history that may make it difficult to evaluate the success of its business …

DA: 24 PA: 23 MOZ Rank: 95

ArTara Therapeutics Completes Merger Transaction With Proteon Therapeutics
drug-dev.com

https://drug-dev.com/artara-therapeutics-completes-merger-transaction-with-proteon-therapeutics/

WebArTara is focused on identifying and optimizing product candidates for patients suffering from rare and specialty diseases where there is a significant unmet need. ArTara’s current development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.

DA: 12 PA: 63 MOZ Rank: 15

Artara
artara.in

https://artara.in/

WebArtara is a unique e-commerce platform where the vibrant pulse of India’s artisanal heritage beats. We bring to you an array of products handcrafted by local artisans from various parts of India, focusing especially on the rich arts and crafts of Uttar Pradesh and Bihar.

DA: 7 PA: 24 MOZ Rank: 95